Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Open in API
Filings indexed 2,316 across all filing types
Latest filing 2025-06-20 AGM Information
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
Newspaper Publication
AGM Information Classification · 90% confidence The document contains multiple distinct sections. The first part is a letter from Dr. Reddy's Laboratories Ltd. regarding a newspaper advertisement about tax deduction on dividend payout, which is an announcement related to dividend information. The second part is a notice from Jayant Agro-Organics Limited about their 33rd Annual General Meeting (AGM) to be held via video conference, including details about the AGM notice, dividend declaration, record date, and voting procedures. This section is a formal notice to shareholders about the AGM and dividend, not the AGM materials or the full annual report itself. The document also includes a possession notice and a notice of loss of share certificates, which are regulatory announcements but do not fit into other specific categories. Given the document's nature as a notice and announcement of the AGM and dividend, and not the actual AGM materials or annual report, the most appropriate classification is AGM Information (AGM-R) because the primary focus is on the AGM notice and related shareholder information. The document length (15,000 characters) supports that it is more than a brief announcement but still primarily an AGM notice and related shareholder communication rather than a full annual report or financial statement.
2025-06-20 English
6-K Filing
Regulatory Filings
2025-06-20 English
FORM 6-K
Regulatory Filings
2025-06-18 English
Allotment of employee stock options
Share Issue/Capital Change Classification · 100% confidence The document is a formal disclosure addressed to multiple stock exchanges regarding the allotment of equity shares on exercise of stock options under the company's ESOP schemes. It references compliance with SEBI regulations, provides detailed information about the shares issued, exercise prices, and the total issued share capital after the allotment. The content is focused on the issuance of new shares due to stock option exercises, which is a capital change event. There is no financial performance data, audit information, or management discussion. The document is not an announcement of a report but a direct disclosure of a share allotment event. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA).
2025-06-14 English
FORM 6-K
Regulatory Filings
2025-06-11 English
Schedule of Analyst/Institutional Investor meet
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of upcoming analyst and institutional investor meetings. It is an intimation under SEBI regulations about investor conference participation. There is no financial data, no detailed report, no voting results, no management changes, and no audit or earnings information. The document is essentially a regulatory announcement about investor meetings, not a report or detailed filing. Given its short length (1455 characters) and content, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-06-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.